Researcher: Corporatization Is Shifting the Incentives Across Healthcare
An academic researcher argues that business activity is rearranging incentives in healthcare
Read More
A inmigrantes con problemas de salud se les podría negar la visa para entrar al país, por nueva directiva del gobierno de Trump
Los extranjeros que solicitan visas para vivir en Estados Unidos podrían ser rechazados si tienen ciertas afecciones médicas, como obesidad o diabetes, según una directiva emitida el jueves 6 de noviembre por la administración Trump. Esta directiva, incluida en un cable enviado por el Departamento de Estado a funcionarios de embajadas y consulados —y revisada…
Immigrants With Health Conditions May Be Denied Visas Under New Trump Administration Guidance
Foreigners seeking visas to live in the U.S. might be rejected if they have certain medical conditions, including diabetes or obesity, under a Thursday directive from the Trump administration. The guidance, issued in a cable the State Department sent to embassy and consular officials and examined by KFF Health News, directs visa officers to deem…
Cigna’s Rebate-Free Model Sounds Nice, But Experts Are Still Skeptical
As lawmakers consider stricter PBM regulation, Cigna launched a “rebate-free” model to give patients upfront drug discounts, but experts question whether it will lead to meaningful change. The post Cigna’s Rebate-Free Model Sounds Nice, But Experts Are Still Skeptical appeared first on MedCity News.
CMS Introduces GENEROUS Model to Lower Medicaid Drug Costs
The new drug payment initiative is designed to negotiate fairer prices for Medicaid
Survey Shows Healthcare Firms Facing Skills Shortage for Implementing GenAI
Despite high enthusiasm among healthcare staff for GenAI, many organizations struggle with deployment challenges
Braveheart Bio Bags $185M for Drug That Could Rival a Bristol Myers Squibb Cardio Med
Braveheart Bio is preparing to advance to Phase 3 testing in obstructive hypertrophic cardiomyopathy, or oHCM. The startup says its small molecule could have safety advantages over Camzyos, a Bristol Myers Squibb capsule projected to become a blockbuster seller in this indication. The post Braveheart Bio Bags $185M for Drug That Could Rival a Bristol…
How Do Enrollees with Private Health Insurance Use Remote Monitoring Technologies?
This Healthy System Tracker analysis, authored by KFF and the Peterson Center on Healthcare, examines remote monitoring technologies, identifying the types of patients and health conditions they serve and what is spent on these services.
Waiting for Codman: 100+ Years of Profits > Patients
By LEONARD D’AVOLIO I’m in the waiting room of the New England Baptist Hospital. They just wheeled my father to the OR. It’s strange to be back. Once upon a time, their Chief Medical Officer, Dr. Scott Tromanhauser asked for my help. He was interested in improving the outcomes of total knee replacement surgeries. Nearly…
What the Health? From KFF Health News: The State of the Affordable Care Act
The Host Julie Rovner KFF Health News @jrovner @julierovner.bsky.social Read Julie’s stories. Julie Rovner is chief Washington correspondent and host of KFF Health News’ weekly health policy news podcast, “What the Health?” A noted expert on health policy issues, Julie is the author of the critically praised reference book “Health Care Politics and Policy A…